2025 DIA China Annual Meeting

Certara is excited to be an exhibitor at 2025 DIA China Annual Meeting, Asia’s premier platform for advancing global collaboration in drug development and regulatory innovation. As a leader in biosimulation and drug development solutions, we look forward to connecting with global regulators, clinical research pioneers, and industry leaders to explore how integrated technologies and expertise accelerate regulatory success across the drug lifecycle.

The FDA’s phaseout of animal testing for mAbs and other drugs is reshaping preclinical development. To stay competitive, companies must adopt AI-driven toxicity models, biosimulation, and New Approach Methodologies (NAMs).

Certara’s Non-Animal Navigator™ accelerates this transition:

1. Gap analysis to pinpoint optimal NAM strategies.
2. Tailored software + services for faster timelines, lower costs, and regulatory confidence.

Stop by our booth to future-proof your pipeline with predictive, animal-free solutions.